SCHEMBL26528200

SCHEMBL26528200

Cc1ccc2nc3n(c2c1)-c1ccccc1C3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.39
ACSS2 Q9NR19 1/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 5/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 3/20 0.35
RAB9A P51151 2/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TP53 P04637 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26528202 0.82 TSHR (0.42) NQO2TSHRMAPTSMN1; SMN2KDM4E
SCHEMBL20041626 0.81 SMN1; SMN2 (0.37) TSHRSMN1; SMN2KDM4ERAB9AGAA
SCHEMBL25592448 0.81 TSHR (0.45) TSHRSMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL18701468 0.76 LMNA (0.32) TSHRSMN1; SMN2RAB9ALMNA
SCHEMBL20041768 0.72 KDM4E (0.40) TSHRSMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL20041733 0.69 ALOX5 (0.46) MAPTSMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL20041515 0.69 TSHR (0.50) NQO2ACSS2TSHRSMN1; SMN2KDM4E
SCHEMBL24120864 0.69 TSHR (0.49) TSHRSMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL31586066 0.68 HPGD (0.48) TSHRMAPTSMN1; SMN2KDM4EALDH1A1
SCHEMBL24329594 0.68 SMN1; SMN2 (0.44) NQO2TSHRMAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793073-B2 Host materials for electroluminescent devices UNIVERSAL DISPLAY CORPORATION (US) 2023-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11793073-B2 Host materials for electroluminescent devices MCM6, MCM2, MCM4 NQO2 3413/4885ACSS2 3658/4885TSHR 4613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.